Sunny Pharmtech Inc.

As of June 30, 2025, Sunny Pharmtech Inc. carries a market capitalization of 2.08B, placing it among publicly traded companies globally. Its enterprise value stands at 2.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2025, Sunny Pharmtech Inc. has 148.82M shares outstanding.

These figures are as of June 30, 2025.

As of June 30, 2025, Sunny Pharmtech Inc. maintains a current ratio of 1.30, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2025.

As of the close on October 22, 2026, Sunny Pharmtech Inc.'s stock has declined approximately 28.79% over the past 52 weeks. The 50-day moving average sits at 11.42, while the 200-day moving average is 13.57.

As of June 30, 2025, Sunny Pharmtech Inc. holds 81.52M in cash and equivalents against 437.79M in total debt, resulting in a net debt position of 313.51M. Total book value stands at 894.85M, with working capital of 75.20M providing operational flexibility.

Sunny Pharmtech Inc.'s most recent stock split took place on July 6, 2023 with a 95:97 split ratio.